670 related articles for article (PubMed ID: 25178429)
1. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
[TBL] [Abstract][Full Text] [Related]
2. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.
Mata IF; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson-Hiller AL; Espay AJ; Revilla FJ; Devoto J; Yearout D; Hu SC; Cholerton BA; Montine TJ; Edwards KL; Zabetian CP
Neurobiol Aging; 2017 Aug; 56():211.e1-211.e7. PubMed ID: 28526295
[TBL] [Abstract][Full Text] [Related]
3. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.
Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Ritz B; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson-Hiller AL; Goldman JG; Stebbins GT; Bernard B; Espay AJ; Revilla FJ; Devoto J; Rosenthal LS; Dawson TM; Albert MS; Tsuang D; Huston H; Yearout D; Hu SC; Cholerton BA; Montine TJ; Edwards KL; Zabetian CP
Mov Disord; 2016 Jan; 31(1):95-102. PubMed ID: 26296077
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
Mengel D; Dams J; Ziemek J; Becker J; Balzer-Geldsetzer M; Hilker R; Baudrexel S; Kalbe E; Schmidt N; Witt K; Liepelt-Scarfone I; Gräber S; Petrelli A; Neuser P; Schulte C; Linse K; Storch A; Wittchen HU; Riedel O; Mollenhauer B; Ebentheuer J; Trenkwalder C; Klockgether T; Spottke A; Wüllner U; Schulz JB; Reetz K; Heber IA; Ramirez A; Dodel R
Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
[TBL] [Abstract][Full Text] [Related]
5. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
[TBL] [Abstract][Full Text] [Related]
6. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
Samaranch L; Cervantes S; Barabash A; Alonso A; Cabranes JA; Lamet I; Ancín I; Lorenzo E; Martínez-Lage P; Marcos A; Clarimón J; Alcolea D; Lleó A; Blesa R; Gómez-Isla T; Pastor P
J Alzheimers Dis; 2010; 22(4):1065-71. PubMed ID: 20930301
[TBL] [Abstract][Full Text] [Related]
7. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults.
Walters S; Contreras AG; Eissman JM; Mukherjee S; Lee ML; Choi SE; Scollard P; Trittschuh EH; Mez JB; Bush WS; Kunkle BW; Naj AC; Peterson A; Gifford KA; Cuccaro ML; Cruchaga C; Pericak-Vance MA; Farrer LA; Wang LS; Haines JL; Jefferson AL; Kukull WA; Keene CD; Saykin AJ; Thompson PM; Martin ER; Bennett DA; Barnes LL; Schneider JA; Crane PK; Hohman TJ; Dumitrescu L;
JAMA Neurol; 2023 Sep; 80(9):929-939. PubMed ID: 37459083
[TBL] [Abstract][Full Text] [Related]
8. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
9. GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study.
Szwedo AA; Dalen I; Pedersen KF; Camacho M; Bäckström D; Forsgren L; Tzoulis C; Winder-Rhodes S; Hudson G; Liu G; Scherzer CR; Lawson RA; Yarnall AJ; Williams-Gray CH; Macleod AD; Counsell CE; Tysnes OB; Alves G; Maple-Grødem J;
Mov Disord; 2022 May; 37(5):1016-1027. PubMed ID: 35106798
[TBL] [Abstract][Full Text] [Related]
10. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
[TBL] [Abstract][Full Text] [Related]
11. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
12. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
O'Hara R; Yesavage JA; Kraemer HC; Mauricio M; Friedman LF; Murphy GM
J Am Geriatr Soc; 1998 Dec; 46(12):1493-8. PubMed ID: 9848808
[TBL] [Abstract][Full Text] [Related]
13. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
14. Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India.
Jairani PS; Aswathy PM; Gopala S; Verghese J; Mathuranath PS
Dement Geriatr Cogn Disord; 2016; 42(5-6):255-264. PubMed ID: 27705964
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
16. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
17. Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study.
Dore GA; Elias MF; Robbins MA; Elias PK; Nagy Z
Diabetologia; 2009 Dec; 52(12):2551-60. PubMed ID: 19693485
[TBL] [Abstract][Full Text] [Related]
18. The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study.
Chung J; Ushakova A; Doitsidou M; Tzoulis C; Tysnes OB; Dalen I; Pedersen KF; Alves G; Maple-Grødem J
Neurosci Lett; 2021 Nov; 764():136243. PubMed ID: 34509566
[TBL] [Abstract][Full Text] [Related]
19. Genetic influences on cognitive decline in Parkinson's disease.
Morley JF; Xie SX; Hurtig HI; Stern MB; Colcher A; Horn S; Dahodwala N; Duda JE; Weintraub D; Chen-Plotkin AS; Van Deerlin V; Falcone D; Siderowf A
Mov Disord; 2012 Apr; 27(4):512-8. PubMed ID: 22344634
[TBL] [Abstract][Full Text] [Related]
20. ABCA7 gene and the risk of Alzheimer's disease in Han Chinese in Taiwan.
Liao YC; Lee WJ; Hwang JP; Wang YF; Tsai CF; Wang PN; Wang SJ; Fuh JL
Neurobiol Aging; 2014 Oct; 35(10):2423.e7-2423.e13. PubMed ID: 24908168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
